ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 442 out of 3647

$896K Total Retail Price of All Prescriptions

Rank: 306 out of 3647

416 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 11,571 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 635 447 S3 1 12
LISINOPRIL 471 402 2 4
OMEPRAZOLE 399 302 3 3
SIMVASTATIN 382 302 4 1
LEVOTHYROXINE SODIUM 350 294 5 5
WARFARIN SODIUM 337 288 6 15
PRAVASTATIN SODIUM 309 258 7 16
FUROSEMIDE 301 229 8 8
AMLODIPINE BESYLATE 282 254 9 2
CITALOPRAM HBR 280 233 10 25
QUETIAPINE FUMARATE 259 209 11 89
RANITIDINE HCL 230 168 12 29
GABAPENTIN 221 173 13 17
CARVEDILOL 200 157 14 20
METFORMIN HCL 179 122 15 6
POTASSIUM CHLORIDE 178 127 16 24
DIOVAN 173 145 17 40
NAMENDA 170 159 18 49
BENZTROPINE MESYLATE 166 141 R 19 222
RISPERIDONE 163 142 20 83
MELOXICAM 163 103 20 33
METOPROLOL TARTRATE 162 123 22 7
LANTUS 152 136 23 59
ESCITALOPRAM OXALATE 148 117 24 65
TRAZODONE HCL 146 71 25 64
MIRTAZAPINE 130 108 26 63
METOPROLOL SUCCINATE 122 100 27 18
LEVETIRACETAM 120 60 28 122
PREDNISONE 119 74 29 43
NOVOLOG 119 95 29 123
SEROQUEL 116 105 31 185
TRAMADOL HCL 116 83 31 22
DONEPEZIL HCL 113 103 33 30
CLOPIDOGREL 112 81 34 26
NOVOLIN R 107 93 35 139
JANUVIA 105 101 36 72
SERTRALINE HCL 105 88 36 27
KLOR-CON M20 96 70 38 121
ADVAIR DISKUS 93 64 39 52
HYDROCHLOROTHIAZIDE 93 68 39 9
ATORVASTATIN CALCIUM 91 56 41 13
SINGULAIR 91 66 41 90
PLAVIX 90 67 43 39
HALOPERIDOL 90 59 43 358
DIGOXIN 89 78 45 51
ZOLPIDEM TARTRATE 89 54 45 14
LEVEMIR FLEXPEN 84 64 47 246
CEFTRIAXONE 83 69 48 305
PHENYTOIN SODIUM EXTENDED 82 64 49 199
DIVALPROEX SODIUM 78 63 50 131
NEXIUM 78 65 50 44
HUMULIN R 76 73 52 370
CIPROFLOXACIN HCL 75 63 53 53
KLOR-CON 10 73 56 54 106
AZITHROMYCIN 69 58 55 34
NOVOLOG FLEXPEN 69 40 55 230
CRESTOR 67 48 57 19
CARBAMAZEPINE 66 61 58 308
LOSARTAN POTASSIUM 64 44 59 11
ALLOPURINOL 62 43 60 37
SPIRIVA 61 38 61 93
TAMSULOSIN HCL 61 47 61 28
ISOSORBIDE MONONITRATE ER 61 56 61 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 34 64 36
ABILIFY 59 46 65 205
AMLODIPINE BESYLATE-BENAZEPRIL 55 47 66 74
GLIPIZIDE 54 50 67 41
OXYBUTYNIN CHLORIDE 52 52 68 107
FAMOTIDINE 51 44 69 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 33 69 110
LEVOFLOXACIN 51 42 69 87
GEMFIBROZIL 51 37 69 82
ALENDRONATE SODIUM 51 51 69 23
FENTANYL 50 41 S2 74 147
MECLIZINE HCL 50 40 74 85
CYMBALTA 50 29 74 79
PEN NEEDLE 50 33 74 166
CARBIDOPA-LEVODOPA 50 47 74 127
NITROFURANTOIN 50 33 74 295
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.